Biology › Section E · Cell communication and the cell cycle › Topic E.2

Passing on and responding to a signal

A ligand binding its receptor is only the handshake. What follows is the conversation: a relay of shape changes, phosphate tags, and small messengers that carries the signal through the cytoplasm, amplifies it, and ends in a handful of responses - a new protein, a burst of fuel, cell division, or the cell's own orderly death.

From binding to a cascade

Once a ligand binds a cell-surface receptor, the signal is transmitted through the membrane into the cytoplasm - signal transduction. It only happens with cell-surface receptors: internal receptors interact directly with DNA. Ligand binding changes the receptor's shape, and that change propagates through the membrane region to activate the intracellular domain; sometimes two receptors bind each other into a dimer, letting their intracellular domains activate each other. The result is a signaling pathway, or cascade: second messengers, enzymes, and activated proteins interact in a chain - events before a point are upstream, after it downstream. Pathways branch toward different endpoints, the same ligand can trigger different responses in different cells (their expressed proteins differ), and separate signals can merge - integration - before a cell commits.

Phosphorylation: the cell's sticky notes

The most common modification in signaling pathways is phosphorylation: adding a phosphate group to a molecule such as a protein - a nucleotide like GMP, or the amino acids serine, threonine, and tyrosine. The transfer is catalyzed by a kinase, and kinases are named for their substrate. Adding a phosphate changes a protein's shape, activating or inactivating it; serine and threonine phosphorylation often activates enzymes, while tyrosine phosphorylation can create a binding site for the next component downstream. Every phosphorylation is reversible: a phosphatase strips the phosphate back off. Kinases and phosphatases together also terminate signals, along with degradation of the signaling molecules themselves.

Second messengers: calcium and cAMP

Second messengers are small molecules that spread a signal through the cytoplasm after receptor binding. Calcium ion is a favorite: ATP-driven pumps keep free cytoplasmic Ca2+ very low, so it is stored in the endoplasmic reticulum or accessed from outside. When signaling opens ligand-gated calcium channels, Ca2+ floods into the cytoplasm - and the response depends on the cell type: in pancreatic beta cells it triggers insulin release; in muscle cells, contraction. Cyclic AMP (cAMP) is another: adenylyl cyclase synthesizes it from ATP, and its main job is activating cAMP-dependent kinase (A-kinase), which phosphorylates serine and threonine on target proteins. A-kinase appears in many cell types with different targets - one messenger, many responses. An enzyme called phosphodiesterase then converts cAMP into AMP, ending the signal.

Second messengers: IP3 and DAG

Inositol phospholipids sit in the plasma membrane at low concentrations, right next to membrane-bound receptors. Kinases phosphorylate phosphatidylinositol (PI) stepwise into PI-phosphate (PIP) and PI-bisphosphate (PIP2). Then phospholipase C cleaves PIP2 into two second messengers with different routes: diacylglycerol (DAG) stays in the membrane and activates protein kinase C (PKC), which phosphorylates serine and threonine on its targets; inositol triphosphate (IP3) diffuses into the cytoplasm and opens ligand-gated calcium channels in the endoplasmic reticulum, releasing stored Ca2+. One cleavage, two messages - one anchored, one mobile.

Response: new proteins

Some pathways regulate transcription of RNA; others regulate translation of proteins from mRNA. When epidermal growth factor (EGF) binds its receptor tyrosine kinase, a phosphorylation cascade activates the MAP kinase ERK, which enters the nucleus and activates a protein kinase that regulates translation. Phosphorylation can also work by inactivating an inhibitor. The protein Iκ-B binds the regulatory protein NF-κB, holding it out of the nucleus; when PKC phosphorylates Iκ-B, it can no longer bind, and NF-κB - a transcription factor - enters the nucleus and initiates transcription.

Response: a burst of fuel

Adrenaline (epinephrine) readies the body for short-term emergencies. In muscle cells it binds β-adrenergic receptors, raising cAMP, which activates protein kinase A (PKA). PKA phosphorylates two enzymes with opposite aims: it activates the kinase chain (glycogen phosphorylase kinase, then glycogen phosphorylase) that catabolizes glycogen into glucose, and it phosphorylates glycogen synthase - inhibiting it, so glucose is not spent rebuilding glycogen. Breaking the storage and blocking the rebuilding at once prevents a futile cycle, leaving the muscle a ready pool of glucose for fight or flight.

Response: divide - or not

Cells do not normally divide unless stimulated by signals from other cells - ligands called growth factors, most of which bind receptor tyrosine kinases (RTKs). Activated RTKs initiate a pathway that includes the G protein RAS, which switches on the MAP kinase pathway to initiate division. The genes encoding these proteins are oncogenes - genes with the potential to cause cancer: when mutation disables the protein, division runs unchecked, and about 30 percent of cancer cells carry a RAS mutation. Herceptin (trastuzumab), a monoclonal antibody, marks the overexpressed HER2 receptor in some breast cancers for immune removal.

Response: programmed death

When a cell is damaged, superfluous, or dangerous, it can trigger apoptosis: programmed cell death, a controlled dismantling that prevents damaging molecules from leaking out. Internal checkpoints monitor cell health and can spontaneously initiate apoptosis; external signals can too. Most normal animal cells anchor to the extracellular matrix, a glycoprotein support network - if a cell detaches, that signaling ceases and it undergoes apoptosis, keeping wandering cells from proliferating out of control. During T-cell development, immature immune cells are screened, and any whose receptor binds the body's own proteins self-destruct. Development itself depends on apoptosis: vertebrate embryos form web-like tissue between developing fingers and toes, and signaling triggers apoptosis there, sculpting fully separated digits.

Worked example: dye in the dish

A dye that cannot cross the plasma membrane suddenly enters cells after a ligand is added to their solution. Which receptor did the ligand bind? Reason it out: the dye got in only after the ligand arrived, so the ligand must have opened a passage through the membrane. That is exactly what an ion channel-linked receptor does: ligand binding changes the channel's shape, opening a hydrophilic pore. Neither G-protein-linked nor enzyme-linked receptors open pores, and an internal receptor is impossible here.

Worked example: the locked switch

In certain cancers, the GTPase activity of the RAS G protein is inhibited: RAS can no longer hydrolyze GTP into GDP. Predict the downstream effect. RAS normally relays a growth-factor signal while GTP-bound and switches off the moment it hydrolyzes GTP. Locked in the GTP-bound state, RAS keeps activating the MAP kinase pathway indefinitely - division proteins keep being expressed, and the cell proliferates without any growth factor asking it to: uncontrolled proliferation. A signaling pathway is only as controlled as its off-switches, which is why RAS mutations drive so many cancers.

Common mistakes to avoid

First, saying internal receptors carry out signal transduction - they act directly on DNA; transduction cascades belong to cell-surface receptors. Second, confusing kinase and phosphatase - kinases add phosphates, phosphatases remove them, and both matter for turning signals on and off. Third, treating amplification as optional - a single ligand-receptor event activates many downstream copies, which is why tiny signals yield big responses. Fourth, assuming a second messenger has one meaning - cAMP or Ca2+ triggers different responses in different cells because the target proteins differ. Fifth, forgetting that signals must be terminated - degradation of signaling molecules and dephosphorylation both end cascades, and a broken off-switch means cancer.

Key takeaways

Signal transduction occurs only through cell-surface receptors: ligand binding changes the receptor's shape, sometimes dimerizing it, and sets off a phosphorylation cascade of kinases (adding phosphates) and phosphatases (removing them), with upstream and downstream events that can branch, integrate, and amplify. Second messengers spread the signal through the cytoplasm: calcium released via ligand-gated channels, cAMP synthesized by adenylyl cyclase from ATP and activating A-kinase, and PIP2 cleaved by phospholipase C into membrane-anchored DAG (activating PKC) and mobile IP3 (releasing ER calcium). Responses fall into four broad kinds: new proteins (ERK promoting translation, NF-κB freed when Iκ-B is phosphorylated), fuel (adrenaline-cAMP-PKA mobilizing glucose while blocking glycogen synthesis), cell division (growth factors, RTKs, RAS, MAP kinase - with oncogenes like mutant RAS driving cancer), and apoptosis, programmed death that sculpts digits, screens T-cells, and kills detached or damaged cells.

Flashcards

Flashcard

signal transduction

Transmission of a signal through the membrane into the cytoplasm after ligand binding

Happens only via cell-surface receptors; internal receptors interact directly with DNA instead.

Test your understanding

Question 1 of 5

Cells are placed in a solution with a dye that cannot cross the plasma membrane. After a ligand is added, the dye enters the cells. What receptor did the ligand most likely bind?

Question 2 of 5

Adrenaline activates PKA in a muscle cell. What does PKA do to glycogen synthase?

Question 3 of 5

A mutation inhibits the GTPase activity of RAS so it cannot hydrolyze GTP to GDP. What is the downstream effect?

Question 4 of 5

During vertebrate development, cells between developing fingers and toes undergo apoptosis. What does this accomplish?

Question 5 of 5

Which enzyme terminates a cAMP signal?

← Previous topicNext topic →